Biotechnology Stocks I Performance Guide: Beam Therapeutics Inc. (BEAM)
BEAM has no dividends
Table and Chart of BEAM Performance
See what a $1,000 investment in BEAM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BEAM Returns | |
|---|---|
| Start Date | Mar-31-2020 |
| Start Price | $18.00 |
| End Date | Dec-01-2023 |
| End Price | $29.57 |
| # Prices | 46 |
| Min Date | Apr-30-2020 |
| Min Price | $15.95 |
| Max Date | Jun-30-2021 |
| Max Price | $128.71 |
| Total Return | 64.28% |
| Annualized Return | 13.83% |
| Current Value of $1,000 Purchase | $1,643 |
| Number Returns | 1,035 |
| Average Return | 24.67% |
| Number Profitable Returns | 402 |
| Percent Profitable Returns | 38.84% |
| Number Unprofitable Returns | 633 |
| Percent Unprofitable Returns | 61.16% |
| Profitable to Unprofitable Returns Ratio | 0.64 |
| BEAM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,410,076,000 | Price to Sales | 29.55 |
| Earnings per Share | $-4.1700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 3.097 |
| PRICE DATA | |
| 52 Week High | $51.6 |
| 52 Week Low | $16.95 |
| Analyst Target Price | $53.69 |
| 50-Day Moving Average | $23.38 |
| 200-Day Moving Average | $29.14 |
| FINANCIAL DATA | |
| Revenue per Share | $1.093 |
| Revenue | $81,554,000 |
| Profit Margin | 0% |
| Return on Equity | -0.381% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BEAM Compare Returns with S&P 500
BEAM Trendline Chart